
CAS 1082744-20-4
:Formula:C20H25N7O2
InChI:InChI=1S/C20H25N7O2/c1-13-10-26(12-17-21-5-2-6-22-17)11-16(13)18-24-19-15(20(28)25-18)9-23-27(19)14-3-7-29-8-4-14/h2,5-6,9,13-14,16H,3-4,7-8,10-12H2,1H3,(H,24,25,28)/t13-,16-/m1/s1
InChI key:IWXUVYOOUMLUTQ-CZUORRHYSA-N
SMILES:C[C@@H]1CN(C[C@H]1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=NC=CC=N5
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
CAS:6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-oneFormula:C20H25N7O2Purity:98%Molecular weight:395.46PF 04447943
CAS:PF 04447943 is a small-molecule, orally bioavailable drug with potential for the treatment of inflammatory bowel disease (IBD). PF 04447943 is a potent inhibitor of TNF-α, which is involved in the pathogenesis of IBD. This compound has been shown to have statistically significant efficacy in wild-type mice and to have low expression in human nuclear DNA. The onset latency of this drug is approximately one week. PF 04447943 inhibits NF-κB and other signal pathways that are involved in the inflammatory response. It also inhibits glutamate dehydrogenase and has shown activity against natural compounds in vitro.
Formula:C20H25N7O2Purity:Min. 95%Molecular weight:395.46 g/molPF-04447943
CAS:PF-04447943, a selective PDE9A inhibitor (IC50=12nM), may aid sickle cell anemia research with its anti-inflammatory properties.Formula:C20H25N7O2Purity:97.01% - 99.36%Color and Shape:SolidMolecular weight:395.4582




